PASADENA, California – A study center in Pasadena and a Los Angeles hospital began participating in a clinical trial for a possible coronavirus vaccine on Wednesday.
Kaiser Permanente’s study and evaluation branch in Pasadena is one of 4 sites in California and Oregon, where approximately 1400 more people will sign up to verify BNT162b2, one of the candidate vaccines being developed through Pfizer Inc. and BioNTech, which are also sponsors of the study. .
The medical syringe is seen with the Pfizer corporate logo shown on a background screen in this representation photo taken in Poland on June 16, 2020 (Photographic representation via Jakub Porzycki / NurPhoto Getty Images)
CONNECTIONS: COVID-19 vaccine applicants provide 3 human trials
Kaiser Permanente Los Angeles Medical Center at 4867 Sunset Blvd is also in the Phase 3 Clinical Trial, with the Kaiser Permanente Center for Health Research in Portland and the Research Division in Oakland.
“This virus is a huge risk to fitness and has profoundly affected the world, both economically and socially,” said Dr. William Towner, lead researcher at the Kaiser in Pasadena.
Advertising
CONNECTION: Stay up-to-date on all information about coronavirus
“It is imperative that we locate an effective vaccine as soon as possible.”
Participants must be adult members of the fitness plan between the ages of 18 and 85 who are not pregnant or have plans to become pregnant during the test.
The phase 3 trial is a randomized trial in which one part of the participants will get the vaccine and the other party will get a placebo. Neither participants nor doctors will know who is getting the placebo vaccine (known as a double-blind study).
During this trial period, knowledge on safety, immune reaction and efficacy will be collected as required by the regulatory review.
Receive last-minute alerts in the FOX News app. Download for iOS or Android.